Proteina KRX:468530KOSDAQ
프로티나 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days2
DART filings, 7 days0
Articles tracked2since Sep 11
In Q2 2026, Proteina reported revenue of ₩349m, down 63.8% year on year, and an operating loss of ₩4.0bn. Proteina (프로티나) appeared in 2 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 2 articles.
Proteina quarterly results separate, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩349m | -63.8% | −₩4.0bn | −₩3.1bn |
| Q1 2026 | ₩169m | -84.1% | −₩4.7bn | −₩3.3bn |
| Q4 2025 derived | ₩343m | -54.6% | −₩4.4bn | −₩3.0bn |
| Q3 2025 | ₩582m | -25.4% | −₩2.9bn | −₩2.6bn |
| Q2 2025 | ₩964m | +26.3% | −₩2.4bn | −₩2.0bn |
| Q1 2025 | ₩1.1bn | – | −₩1.6bn | −₩1.4bn |
| Q4 2024 derived | ₩757m | – | −₩2.7bn | −₩1.8bn |
| Q3 2024 | ₩781m | – | −₩2.0bn | −₩1.5bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Proteina top stories 2 weeks, by number of outlets
- 1
Latest Proteina news Korean headlines
-
“AI 신약 10만개 중 진짜는?”…프로티나, 대규모 실험검증으로 후보물질 선별
1 more on this story · 1 outlets
- “AI 신약 10만개 중 진짜는?”…프로티나, 대규모 실험검증으로 후보물질 선별이데일리 · Sep 14 08:01